|
Sandoz, a Novartis division, is the
pioneer and global leader in biosimilars with a state-of-the-art European
production, and 70 years of biotechnology expertise1. We have 8
biologics approved in the EU including 4 in immunology, and our biologics are
marketed in 86 countries.
References:
1. Bud R (20071. Bud R (2007). Penicillin: Triumph & Tragedy. Great Britain: Oxford University Press.
|
